{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:06:24Z","timestamp":1783724784188,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pcd.2025.05.002","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T23:53:04Z","timestamp":1746575584000},"page":"368-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating risk stratification according to Type 2 diabetes guidelines in primary care \u2013 Insights from the Danish DIAGRAM project"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0327-9564","authenticated-orcid":false,"given":"Morten H.","family":"Charles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Schousboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5448-1208","authenticated-orcid":false,"given":"Tanja","family":"Thybo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben Krogh","family":"Hall-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-6157","authenticated-orcid":false,"given":"S\u00f8ren Tang","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2025.05.002_bib1","unstructured":"International Diabetes Foundation. Diabetes Atlas 2021. \u3008https:\/\/diabetesatlas.org\/data\/en\/indicators\/21\/\u3009, accessed December 2024."},{"issue":"2","key":"10.1016\/j.pcd.2025.05.002_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pcd.2020.09.006","article-title":"Risk factor management of type 2 diabetic patients in primary care in the Scandinavian countries between 2003 and 2015","volume":"15","author":"Knudsen","year":"2021","journal-title":"Prim. Care Diabetes"},{"issue":"4","key":"10.1016\/j.pcd.2025.05.002_bib3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/dom.14947","article-title":"Changes in the use of glucose-lowering drugs: a Danish nationwide study","volume":"25","author":"Pottegard","year":"2023","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.pcd.2025.05.002_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12020183","article-title":"Cardiovascular and renal effectiveness of GLP-1 receptor agonists vs. other glucose-lowering drugs in type 2 diabetes: a systematic review and meta-analysis of real-world studies","volume":"12","author":"Caruso","year":"2022","journal-title":"Metabolites"},{"issue":"7","key":"10.1016\/j.pcd.2025.05.002_bib5","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/03007995.2019.1576479","article-title":"The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes","volume":"35","author":"Woo","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.pcd.2025.05.002_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pcd.2025.05.002_bib7","unstructured":"Danish College of Endocrinology. Type 2 diabetes. \u3008https:\/\/endocrinology.dk\/nbv\/diabetes-melitus\/behandling-og-kontrol-af-type-2-diabetes\/\u3009, accessed December 2024."},{"key":"10.1016\/j.pcd.2025.05.002_bib8","unstructured":"Danish Society of General Practitioners. Pharmacologic management of Type 2 diabetes (Farmakologisk behandling af type 2-diabetes). \u3008https:\/\/www.dsam.dk\/vejledninger\/fb-type2\u3009, accessed December 2024."},{"issue":"11","key":"10.1016\/j.pcd.2025.05.002_bib9","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2025.05.002_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-8587(20)30343-0","article-title":"Guideline recommendations and the positioning of newer drugs in type 2 diabetes care","volume":"9","author":"Marx","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pcd.2025.05.002_bib11","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO). 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. \u3008https:\/\/kdigo.org\/wp-content\/uploads\/2022\/10\/KDIGO-2022-Clinical-Practice-Guideline-for-Diabetes-Management-in-CKD.pdf\u3009, accessed December 2024."},{"issue":"28","key":"10.1016\/j.pcd.2025.05.002_bib12","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","article-title":"SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe","volume":"44","author":"SCORE2-Diabetes Working Group and ESC Cardiovascular Risk Collaboration","year":"2023","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.pcd.2025.05.002_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.pcd.2021.07.003","article-title":"Improving frequency of urinary albumin testing in type 2 diabetes in primary care - an analysis of cross-sectional studies in Denmark","volume":"15","author":"Persson","year":"2021","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.pcd.2025.05.002_bib14","article-title":"The management of chronic kidney disease in primary care in denmark: patient characteristics, treatment, follow-up, progression, and referral","author":"Birn","year":"2024","journal-title":"Clin. Kidney J."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991825001007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991825001007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:44:48Z","timestamp":1762555488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991825001007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1751991825001007"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2025.05.002","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating risk stratification according to Type 2 diabetes guidelines in primary care \u2013 Insights from the Danish DIAGRAM project","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2025.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.","name":"copyright","label":"Copyright"}]}}